Log in

Start Your Membership Now

Lately headlines involving pharmaceuticals have become more commonplace — a few recent stories from the OPEN MINDS Weekly News Wire reminded me of the many new developments in this area. Most recently, these developments focused on the opioid crisis (see FDA Approves Six-Month Implant For Opioid Addiction Treatment), new research incubators (see Janssen Launches New Research Platforms For Disease Prevention), and most recently, the expansion of value-based reimbursement models for medications. Just as value-based care is shaping service delivery in health and human services, we're seeing new value-based models being applied to medication management.

Last year . . .

Want To Read More? Log In Or Become A Paid Member
Resource Available For Paid OPEN MINDS Circle Members Only
Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!
Log In
If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

Become A Paid Member
If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.